Bupropion versus other antidepressive agents for depression

  • Protocol
  • Intervention

Authors

  • Toshi A Furukawa,

    Corresponding author
    1. Kyoto University Graduate School of Medicine / School of Public Health, Department of Health Promotion and Human Behavior, Kyoto, Japan
    • Toshi A Furukawa, Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Yoshida Konoe-cho, Sakyo-ku,, Kyoto, 606-8501, Japan. furukawa@kuhp.kyoto-u.ac.jp.

    Search for more papers by this author
  • Yusuke Ogawa,

    1. Kyoto University Graduate School of Medicine / School of Public Health, Department of Health Promotion and Human Behavior, Kyoto, Japan
    Search for more papers by this author
  • Nozomi Takeshima,

    1. Kyoto University Graduate School of Medicine / School of Public Health, Department of Health Promotion and Human Behavior, Kyoto, Japan
    Search for more papers by this author
  • Yu Hayasaka,

    1. Kyoto University Graduate School of Medicine / School of Public Health, Department of Health Promotion and Human Behavior, Kyoto, Japan
    Search for more papers by this author
  • Peiyao Chen,

    1. Kyoto University Graduate School of Medicine / School of Public Health, Department of Health Promotion and Human Behavior, Kyoto, Japan
    Search for more papers by this author
  • Andrea Cipriani,

    1. University of Oxford, Department of Psychiatry, Oxford, UK
    Search for more papers by this author
  • Corrado Barbui

    1. University of Verona, Department of Public Health and Community Medicine, Section of Psychiatry, Verona, Italy
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to comprehensively assess evidence for the effects of bupropion in comparison with all other anti-depressive agents in the acute phase treatment of major depression. Objectives include the following.

1.       To determine the efficacy of bupropion in alleviating the acute symptoms of depression in comparison with other anti-depressive agents.

2.       To review acceptability of treatment with bupropion in comparison with other anti-depressive agents.

3.       To investigate the side effects of bupropion in comparison with other anti-depressive agents.